USPTO serial 79426139
OLIGOCREATOR
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BELL,JUNA QUEEN
- Law office
- TMO LAW OFFICE 133
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with OLIGOCREATOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture product, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by the use of bioinformatics techniques; development of pharmaceutical products by the use of bioinformatics techniques being testing and diagnostic procedures; bioinformatic services for scientific research purposes in the pharmaceutical and biotechnological industry, namely, computational design and optimization of oligonucleotide sequences, sequence analysis of nucleic acids, target identification and validation using bioinformatic methods, in silico screening and prediction of efficacy, safety and off-target effects of nucleic acid therapeutics, analysis of gene expression and multiomics data, integration and analysis of biological data sets, selection of candidate oligonucleotides based on computational and experimental data, application of artificial intelligence and machine learning for drug discovery and sequence optimization, and scientific and technological services in the field of oligonucleotide research and nucleic acid therapeutics; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standards | ACTIVE | — |
| 044 | Consultancy services to third parties in the field of biochemistry and nucleic acids and bioinformatics, namely, using antisense technology for the development of pharmaceutical products; consultancy services to third parties in the field of the evaluation of safety and efficacy of pharmaceuticals | ACTIVE | — |
| 045 | Licensing of industrial property rights arising from scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture products, in particular molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the design of pharmaceutical active ingredients using molecular biology techniques, especially antisense techniques; licensing of industrial property rights arising from the development of pharmaceutical products using molecular biology techniques being testing and diagnostic procedures; licensing of industrial property rights arising from bioinformatic services for the pharmaceutical and biotechnological industry; licensing of industrial property rights arising from the services for evaluating the efficacy and safety of pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 14, 2026 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 21, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 7, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 7, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 23, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 23, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 19, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |